© 2004 - 2008
All rights reserved.
Northern California
Melanoma Center
Disclaimer
Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor
(PDF)
Low-Dose Outpatient Chemobiotherapy With Temozolomide, Granulocyte-Macrophage Colony Stimulating Factor, Interferon-aplha2b, and Recombinant Interleukin-2 for the Treatment of Metastatic Melanoma
(PDF)
Noninterferon-based Adjuvant Therapy for High Risk Melanoma
(PDF)
Value of Alpha Interferon in Adjuvant Therapy for Melanoma: The Case Against
(PDF)